Obesity-related physiological changes resulted in a 32% reduction in posaconazole exposure in obese individuals compared to lean individuals due to the higher clearance of UGT substrates, while the opposite was found for the washout half-life, due to the higher distribution in adipose tissue. The gene discussed is SLC35A2; the disease is Obesity.